Commerce Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

Commerce Bank’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-24,300	Closed	-$473K	–	892
2018 Q1	$473K	Sell	24,300 -75	-0.3%	-$1.47K	0.01%	573
2017 Q4	$406K	Buy	24,375 +12,915	+113%	+$237K	0.01%	631
2017 Q3	$232K	Hold	11,460	–	–	﹤0.01%	771
2017 Q2	$184K	Hold	11,460	–	–	﹤0.01%	797
2017 Q1	$145K	Buy	11,460 +1,310	+13%	+$15.8K	﹤0.01%	783
2016 Q4	$135K	Sell	10,150 -1,800	-15%	-$30.8K	﹤0.01%	791
2016 Q3	$283K	Hold	11,950	–	–	﹤0.01%	669
2016 Q2	$345K	Buy	11,950 +2,240	+23%	+$73K	0.01%	602
2016 Q1	$311K	Buy	+9,710	New	+$341K	0.01%	629

Commerce Bank's IPXL Position: Q2 2018 in Review

Commerce Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 24,300 shares — an estimated $473K sold.

Commerce Bank first reported a position in IPXL in Q1 2016 and held it in 9 quarters. The position peaked at $473K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Commerce Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Commerce Bank sold 24,300 Impax Laboratories, Inc. shares in Q2 2018, an estimated $473K.
Commerce Bank first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 9 quarters.
Commerce Bank's Impax Laboratories, Inc. position peaked at $473K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Commerce Bank's 13F filing for Q2 2018, filed 8 Aug 2018.